Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 1 Dec 2005 |
| Genmab, Capital Increase in Genmab as a Result of Employee Warrant Exercise | 1 Dec 2005 |
| Genmab, articles of association | 8 Nov 2005 |
| Genmab, quarterly report Q3 2005 | 8 Nov 2005 |
| Genmab, Announces Results for the First Nine Months of 2005 | 8 Nov 2005 |